Literature DB >> 8167339

Alteration of fibrin network by activated protein C.

A Gruber1, E Mori, G J del Zoppo, L Waxman, J H Griffin.   

Abstract

The antithrombotic plasma enzyme, activated protein C (APC), may play a role in thrombolysis. In vitro, acceleration of clot lysis by APC depends on its ability to inhibit the activation of prothrombin. The effect of APC on the assembly and dispersion of fibrin network was studied using turbidimetry, plasmin digestion of fibrin, and electron microscopy of plasma clots. The addition of APC before clotting but not after clotting accelerated clot lysis. The rate of increase in the turbidity of clotting plasma was reduced by APC. The turbidity of plasma clots containing APC was directly related to the clot lysis time. Fibrin from plasma clots that were formed in the presence of APC yielded less fibrin degradation products than fibrin from clots without added APC. Furthermore, APC reduced the diameter and relative number of fibrin fibers in plasma clots during gel assembly. We propose that APC may enhance the efficacy of thrombolysis by reducing the relative mass of fibrin within maturing thrombi.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8167339

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

1.  Cardiac intraventricular thrombus in protein C deficiency.

Authors:  K S Nair; A Weerasinghe; M Dahdal; J S Gibbs; J R Anderson
Journal:  J R Soc Med       Date:  2001-12       Impact factor: 5.344

2.  Cardiac left ventricular thrombus in protein C deficiency.

Authors:  Feridoun Sabzi; Reza Faraji
Journal:  Niger Med J       Date:  2014-07

3.  Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation.

Authors:  P Gresele; S Momi; M Berrettini; G G Nenci; H P Schwarz; N Semeraro; M Colucci
Journal:  J Clin Invest       Date:  1998-02-01       Impact factor: 14.808

4.  Polyphosphate enhances fibrin clot structure.

Authors:  Stephanie A Smith; James H Morrissey
Journal:  Blood       Date:  2008-06-10       Impact factor: 22.113

5.  Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XI.

Authors:  Erik I Tucker; Ulla M Marzec; Tara C White; Sawan Hurst; Sandra Rugonyi; Owen J T McCarty; David Gailani; András Gruber; Stephen R Hanson
Journal:  Blood       Date:  2008-10-22       Impact factor: 22.113

6.  Coil embolization of inferior epigastric artery pseudoaneurysm after percutaneous thrombin injection failure: a case report.

Authors:  Miltiadis Krokidis; Adam Hatzidakis; John Petrakis; Theodoros Lagoudis; Dimitrios Tsetis
Journal:  Cases J       Date:  2009-08-12

7.  Cerebral Vein Thrombosis Post CABG Precipitated by Malposition of Subclavian Central Catheter in Protein C & S Deficiency Patient.

Authors:  Feridoun Sabzi; Reza Faraji
Journal:  Ethiop J Health Sci       Date:  2015-07

8.  Ultrasound-guided thrombin injection for treatment of iatrogenic femoral artery pseudoaneurysms compared with open surgery: first experiences from a single institution.

Authors:  Onur Saydam; Deniz Serefli; A Yaprak Engin; Mehmet Atay
Journal:  Ann Surg Treat Res       Date:  2020-04-28       Impact factor: 1.859

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.